IN187487B - - Google Patents

Info

Publication number
IN187487B
IN187487B IN133BO1999A IN187487B IN 187487 B IN187487 B IN 187487B IN 133BO1999 A IN133BO1999 A IN 133BO1999A IN 187487 B IN187487 B IN 187487B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Joyendu Jagadindu Chaudhuri
Original Assignee
M S Alembic Chemical Works Com
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M S Alembic Chemical Works Com filed Critical M S Alembic Chemical Works Com
Priority to IN133BO1999 priority Critical patent/IN187487B/en
Publication of IN187487B publication Critical patent/IN187487B/en

Links

IN133BO1999 1999-02-25 1999-02-25 IN187487B (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN133BO1999 IN187487B (enrdf_load_stackoverflow) 1999-02-25 1999-02-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN133BO1999 IN187487B (enrdf_load_stackoverflow) 1999-02-25 1999-02-25

Publications (1)

Publication Number Publication Date
IN187487B true IN187487B (enrdf_load_stackoverflow) 2002-05-04

Family

ID=29596532

Family Applications (1)

Application Number Title Priority Date Filing Date
IN133BO1999 IN187487B (enrdf_load_stackoverflow) 1999-02-25 1999-02-25

Country Status (1)

Country Link
IN (1) IN187487B (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US7625507B2 (en) 2003-12-04 2009-12-01 Pfizer Inc. Extrusion process for forming chemically stable drug multiparticulates
US7736672B2 (en) 2003-12-04 2010-06-15 Pfizer, Inc. Multiparticulate compositions with improved stability
US7887844B2 (en) 2003-12-04 2011-02-15 Pfizer Inc. Multiparticulate crystalline drug compositions having controlled release profiles
US7951403B2 (en) 2003-12-04 2011-05-31 Pfizer Inc. Method of making pharmaceutical multiparticulates

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US7625507B2 (en) 2003-12-04 2009-12-01 Pfizer Inc. Extrusion process for forming chemically stable drug multiparticulates
US7736672B2 (en) 2003-12-04 2010-06-15 Pfizer, Inc. Multiparticulate compositions with improved stability
US7887844B2 (en) 2003-12-04 2011-02-15 Pfizer Inc. Multiparticulate crystalline drug compositions having controlled release profiles
US7951403B2 (en) 2003-12-04 2011-05-31 Pfizer Inc. Method of making pharmaceutical multiparticulates

Similar Documents

Publication Publication Date Title
BE2018C020I2 (enrdf_load_stackoverflow)
BE2016C007I2 (enrdf_load_stackoverflow)
BE2013C015I2 (enrdf_load_stackoverflow)
JP2002533171A5 (enrdf_load_stackoverflow)
BRPI0017527B8 (enrdf_load_stackoverflow)
JP2002530521A5 (enrdf_load_stackoverflow)
JP2002522224A5 (enrdf_load_stackoverflow)
JP2002524942A5 (enrdf_load_stackoverflow)
BRPI0001672A2 (enrdf_load_stackoverflow)
JP2002514464A5 (enrdf_load_stackoverflow)
HU0005001D0 (enrdf_load_stackoverflow)
BRPI0001542A2 (enrdf_load_stackoverflow)
JP2002519715A5 (enrdf_load_stackoverflow)
BRPI0012675B8 (enrdf_load_stackoverflow)
JP2002531256A5 (enrdf_load_stackoverflow)
JP2002505949A5 (enrdf_load_stackoverflow)
BRPI0017522A2 (enrdf_load_stackoverflow)
JP2002518621A5 (enrdf_load_stackoverflow)
IN187487B (enrdf_load_stackoverflow)
JP2002533952A5 (enrdf_load_stackoverflow)
JP2001180351A5 (enrdf_load_stackoverflow)
JP2000152795A5 (enrdf_load_stackoverflow)
BRMU7902607U2 (enrdf_load_stackoverflow)
BRPI9917761A2 (enrdf_load_stackoverflow)
IN191485B (enrdf_load_stackoverflow)